Latest Grant Funding News

Delorean is repositioning itself from an engineering contractor into an owner and operator of renewable gas infrastructure, with five projects representing $214 million of stated total capital expenditure. The near-term test is whether it can close funding for NSW1 while bringing its largely completed Salisbury plant into revenue.

EcoGraf has completed a A$4.727 million capital raising to support debt financing and development work at its Epanko graphite project in Tanzania. The raise combines a shareholder-backed SPP with a discounted placement to institutional and sophisticated investors.

International Graphite has moved its graphite processing strategy from plans towards construction and joint ventures, but the FY2026 annual report shows the company remains loss-making and reliant on external funding. Collie is scheduled for building completion in Q2 2027, while the proposed European hub still requires financing and development work.

EcoGraf’s underwritten share purchase plan raised $3.552 million, well above its $2 million target, after shareholders applied for the full oversubscription. The result gives the company additional funding while leaving the final issue price and dilution to be confirmed.

Li-S Energy has narrowed its FY26 loss and reached several commercialisation milestones, including a 2C Power Cell, international shipping approvals and its first lithium foil sale. But the ASX battery developer still needs customer offtake and fresh funding before its proposed 1 GWh manufacturing expansion can become reality.

EMVision Medical Devices has received a $4.3 million R&D tax refund, adding non-dilutive funding as it progresses clinical work on its emu™ and First Responder devices. The cash arrives against a last reported cash balance of $17.1 million and $4.6 million in remaining grant funding at 30 June 2026.

Australian Vanadium reported progress across its mine, electrolyte and battery businesses, but auditors highlighted material uncertainty over the company’s ability to continue as a going concern. The group held $17.9 million in cash at 30 June, yet expects to need additional funding within 12 months.

Cobalt Blue has cleared important technical and regulatory hurdles at its Kwinana refinery, but the pre-revenue developer says further funding is needed and auditors flagged material uncertainty over its ability to continue as a going concern. The company reported an A$8.797 million loss for FY2026 despite ending the year with A$4.265 million in cash.

EcoGraf has begun a European Investment Bank-funded study program worth up to €2 million to test expansion options for its Epanko graphite project and planned battery anode operations. The work could strengthen future financing and development decisions, but it remains a planning exercise rather than a construction commitment.

Li-S Energy says its Geelong lithium-sulfur production line is complete and has delivered 10Ah Power Cells to the US Army for testing. The company is targeting its first commercial battery sale in 2027, while holding A$15.6 million in cash and investments and A$9.3 million in secured grants yet to be received.

ABx Group and its ALCORE subsidiary have received nearly $600,000 in R&D tax offsets, while ALCORE has completed repayment of $2.61 million in unused government grant funds. The company is now awaiting a decision on a separate Industry Growth Program application worth up to $5 million.

A multimillion-dollar, multiyear NIH grant will fund an expanded access program for Neurizon’s investigational NUZ-001, potentially giving up to 200 US patients access to the therapy for as long as 96 weeks. The program is designed to add long-term safety, survival and biomarker data alongside the pivotal HEALEY ALS trial.